Antiplatelet Monotherapy After Percutaneous Coronary Intervention. Contemporary Long-term Outcomes and Matched Comparison With Routine Clinical Practice
Rev Esp Cardiol (Engl Ed). 2018 Nov;71(11):984-986.
doi: 10.1016/j.rec.2017.10.001.
Epub 2017 Oct 31.
[Article in
English,
Spanish]
Affiliations
- 1 Unidad de Cardiología Intervencionista, Instituto Cardiovascular, Hospital Clínico San Carlos, Madrid, Spain. Electronic address: [email protected].
- 2 Unidad de Cardiología Intervencionista, Instituto Cardiovascular, Hospital Clínico San Carlos, Madrid, Spain.
- 3 Departamento de Cardiología Intervencionista, Hospital Infermi, Rivoli, Turin, Italy; Departamento de Cardiología, Hospital Universitario San Luigi, Orbassano, Turin, Italy.
No abstract available
MeSH terms
-
Aged
-
Coronary Restenosis / drug therapy*
-
Female
-
Follow-Up Studies
-
Humans
-
Male
-
Percutaneous Coronary Intervention*
-
Platelet Aggregation Inhibitors / therapeutic use
-
Postoperative Care / methods*
-
Ticlopidine / therapeutic use*
-
Time Factors
-
Treatment Outcome
Substances
-
Platelet Aggregation Inhibitors
-
Ticlopidine